Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.
Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.
Synonyms: propionyl-CoA carboxylase deficiency, ketotic hyperglycinaemia
This is a rare metabolic disorder which can present with vomiting, dehydration and encephalopathy but also with developmental delay and haematological disorders.
- The condition predisposes to stroke, specifically bilateral infarcts of the basal ganglia involving caudate, putamen and globus pallidus.
- Milder forms of the condition exist.
- It may be underdiagnosed.
- Propionyl-CoA is an important intermediate in the metabolism of several amino acids and is also produced by oxidation of odd-numbered fatty acids. Patients are intolerant to protein.
- This is a genetic defect of metabolism, inherited as an autosomal recessive.
- The enzyme propionyl co-enzyme A (CoA) carboxylase is deficient.
- Severe ketoacidosis is precipitated by ingestion of protein.
- A defect has been described at gene map locus 3q21-q22 but another variation with a defect on chromosome 13 has been described and there may be a few variations of the condition.[1, 2]Online Mendelian Inheritance in Man (OMIM) lists eight.
- The problem lies in the metabolism of the amino acids isoleucine, valine, threonine and methionine. They are essential amino acids and so management is based on keeping their dietary content low rather than total exclusion.
- It is a rare condition that on a worldwide basis probably affects about 1 child in 100,000 births.
- Mild forms of the disease are probably more common and the true incidence may be as high as 1 case in 18,000 of the population.
- In certain areas like Saudi Arabia, the incidence may be as high as 1 in 2,000 to 5,000 births.
- It is difficult to assess how much is due to spontaneous mutation.
- Many cases may not be diagnosed and so the incidence may be rather higher than suspected.
- Consanguineous marriage is a common risk factor.
The fetus is protected in utero by the mother's circulation and metabolism and so presentation is often in infancy. This will depend upon the degree of deficiency of the enzyme. Some have divided patients into two subgroups:
- Present within the first week of life.
- General learning disability.
- Early death.
- Present after 6 weeks of age and can (in mild forms of the disease) present much later in life.
- Characterised by severe movement disorders and dystonias.
- Presentation can be with severe ketoacidosis and pH as low as 6.8. There is shock, hypoxia and there may be serious brain damage. Death can result.
- A more usual presentation is failure to thrive with feeding intolerance.
- Excessive levels of ammonia produce a repeated insult to the brain that causes general learning disability. Somnolence is common.
- An attack is followed by pancytopenia that predisposes to overwhelming and possibly fatal infection. The presence of infection to account for illness makes it easy to overlook the metabolic defect.
- Usually there is no family history but sometimes an older infant or young child may have a long history of episodic lethargy, anorexia, vomiting and acidosis that responds to short hospital stays with intravenous glucose and bicarbonate administration.
- Cardiomyopathy can be rapid and fatal.
- Psychosis has been reported as a late presentation.
- Aseptic meningitis.
- Haemophilus meningitis.
- Basilar artery thrombosis.
- Posterior cerebral artery stroke.
- Metabolic disorders:
- Infective endocarditis (neurological complications).
- Tuberous sclerosis.
- Haematological disorders:
The following findings help to confirm the diagnosis:
- Urine will show ketones. This is unusual in infants and should raise suspicion.
- There is metabolic acidosis with serum electrolytes showing a raised anion gap (normal range 10-18 mmol/L).
- Blood ammonia is elevated. This indicates the cause for disturbance of mental status.
- Plasma lactate is often raised but not enough to account for the anion gap. This should also raise suspicion.
- Urinary organic acids confirm the diagnosis. Large increases in beta-hydroxy propionic acid, lactic acid and methylcitrate excretion are found.
- The ultimate test is leukocyte propionyl-CoA carboxylase activity. It gives definitive biochemical diagnosis and allows genetic counselling.
- If the diagnosis is not made in life it is unlikely to be made post-mortem.
However, it is likely that the full work-up of patients presenting with typical (but nonspecific) signs and symptoms will include a wider range of tests in keeping with the differential diagnoses outlined. Inborn errors of metabolism present in a variety of ways (five main presentations have been observed) and faced with an infant's deteriorating condition, emergency treatment and investigations have to be pursued.These will include, for example:
- FBC (often reveals neutropenia and thrombocytopenia), electrolytes and blood gases.
- Blood glucose (to exclude other causes of acidosis).
- LFTs (to exclude acidosis from liver disease).
- Full range of imaging investigations (appropriate for a young patient with stroke).
The severe metabolic ketoacidosis in this disorder requires vigorous alkali therapy and protein restriction. Ammonia, acid-base balance and anion gap are important biochemical indicators to identify metabolic decompensation and to assess severity.Oral antibiotic therapy to reduce gut propionate production may also prove useful.
- Usually the child is severely unwell on presentation and the clinical imperative is the correction of the ketoacidosis, dehydration and electrolyte imbalance. Fluid, electrolytes and bicarbonate are required. Sometimes glucose and insulin are required.
- A temporary cessation of intake of protein is required, after which the offending amino acids should be permitted in very limited amounts. A protein intake below 1.5 grams per kilogram body weight per day is often required.
- If breast-feeding occurs it must be monitored carefully.
- Diet should be individualised with the aim of restricting propiogenic substrates (valine, methionine, isoleucine, threonine and odd chain fatty acids), while encouraging normal protein synthesis and preventing protein catabolism, amino acid deficiencies and growth restriction.
- L-carnitine supplementation at a dose of 50-100 mg/kg/day should be given.
- Oral metronidazole given intermittently at a dose of 10-20 mg/kg/day helps to reduce propionate production by gut bacteria.
- Anti-epileptic medication and therapy of arrhythmias may be needed.
- Orthoptic liver transplantation (replacement of all or part of the liver with a donor liver in the same anatomical position) is indicated in patients with frequent metabolic decompensations, uncontrollable hyperammonaemia and restricted growth. Pre-operatively it is important to minimise the severity of metabolic acidosis by maintaining optimal tissue perfusion, avoiding hypotension, preventing hypoglycemia and providing bicarbonate.
- Continuous haemofiltration, extracorporeal membrane oxygenation (ECMO) and left ventricular assist devices have been used while awaiting liver transplant.
- Strict adherence to the diet is required.
- Brain damage is common and life expectancy limited.
- Heart failure and cardiomyopathy are commonly reported causes of mortality.
- The degree of deficiency of the enzyme has great prognostic significance.
- After genetic counselling it is possible to offer prenatal testing with a view to termination of pregnancy (TOP) as the prognosis is so very poor. If two carriers have been identified (eg when investigating the cause of death of a previous offspring) it may be possible to perform preimplantation genetic diagnosis (PGD). In this technique, embryos conceived by in vitro fertilisation are tested and only those which are healthy are implanted into the uterus.
- Prenatal testing can be performed:
- Amniocentesis: propionic acidaemia can be diagnosed either by an elevated quantity of the metabolite methylcitrate in amniotic fluid or by deficient activity of propionyl-CoA carboxylase in amniocytes.
- Chorionic villous sampling: prenatal diagnosis of an affected fetus, based on DNA analysis in chorionic villus tissue, can also be performed.
- Screening has been suggested but it is a rare condition that can be missed by the test and it is doubtful whether this improves quality of life or gives value for money.
Further reading and references
Vernon HJ, Bagnasco S, Hamosh A, et al; Chronic kidney disease in an adult with propionic acidemia. JIMD Rep. 201412:5-10. doi: 10.1007/8904_2013_237. Epub 2013 Jun 12.
Proprionic Acidemia; Online Mendelian Inheritance in Man (OMIM)
Propionyl-CoA Carboxylase, Beta Subunit; PCCB Online Mendelian Inheritance in Man (OMIM)
Carrillo-Carrasco, N; Propionic Acidaemia, 2012.
Ardoin KB, Moodie DS, Snyder CS; Rate-dependent left bundle-branch block in a child with propionic aciduria. Ochsner J. 2009 Summer9(2):65-7.
Karimzadeh P, Jafari N, Ahmad Abadi F, et al; Propionic acidemia: diagnosis and neuroimaging findings of this neurometabolic disorder. Iran J Child Neurol. 2014 Winter8(1):58-61.
Rafique M; Clinical spectrum of propionic acidaemia. J Nutr Metab. 20132013:975964. doi: 10.1155/2013/975964. Epub 2013 Oct 31.
Dejean de la Batie C, Barbier V, Valayannopoulos V, et al; Acute psychosis in propionic acidemia: 2 case reports. J Child Neurol. 2014 Feb29(2):274-9. doi: 10.1177/0883073813508812. Epub 2013 Dec 11.
Long S et al; Principles and Practice of Pediatric Infectious Diseases, 2012.
Saudubray JM, Nassogne MC, de Lonlay P, et al; Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol. 2002 Feb7(1):3-15.
Christopher R, Sankaran BP; An insight into the biochemistry of inborn errors of metabolism for a clinical neurologist. Ann Indian Acad Neurol. 2008 Apr11(2):68-81. doi: 10.4103/0972-2327.41873.
Zwickler T, Riderer A, Haege G, et al; Usefulness of biochemical parameters in decision-making on the start of emergency treatment in patients with propionic acidemia. J Inherit Metab Dis. 2014 Jan37(1):31-7. Epub 2013 Jun 25.
Huner G, Baykal T, Demir F, et al; Breastfeeding experience in inborn errors of metabolism other than phenylketonuria. J Inherit Metab Dis. 200528(4):457-65.
Ryu J, Shin YH, Ko JS, et al; Intractable metabolic acidosis in a child with propionic acidemia undergoing liver transplantation -a case report-. Korean J Anesthesiol. 2013 Sep65(3):257-61. doi: 10.4097/kjae.2013.65.3.257. Epub 2013 Sep 25.
Grunert SC, Mullerleile S, De Silva L, et al; Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis. 2013 Jan 108:6. doi: 10.1186/1750-1172-8-6.
Pena L, Burton BK; Survey of health status and complications among propionic acidemia patients. Am J Med Genet A. 2012 Jul158A(7):1641-6. doi: 10.1002/ajmg.a.35387. Epub 2012 Jun 7.
Alberola TM, Bautista-Llacer R, Vendrell X, et al; Case report: birth of healthy twins after preimplantation genetic diagnosis of propionic acidemia. J Assist Reprod Genet. 2011 Mar28(3):211-6. doi: 10.1007/s10815-010-9514-4. Epub 2010 Dec 3.
Dionisi-Vici C, Deodato F, Roschinger W, et al; 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis. 2006 Apr-Jun29(2-3):383-9.